1. Home
  2. LNN vs SGP Comparison

LNN vs SGP Comparison

Compare LNN & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lindsay Corporation

LNN

Lindsay Corporation

N/A

Current Price

$106.04

Market Cap

1.1B

Sector

Industrials

ML Signal

N/A

Logo SpyGlass Pharma Inc. Common Stock

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$35.22

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LNN
SGP
Founded
1954
2019
Country
United States
United States
Employees
N/A
65
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
1995
2026

Fundamental Metrics

Financial Performance
Metric
LNN
SGP
Price
$106.04
$35.22
Analyst Decision
Hold
Strong Buy
Analyst Count
4
6
Target Price
★ $122.00
$44.00
AVG Volume (30 Days)
★ 150.6K
84.2K
Earning Date
10-22-2026
11-17-2026
Dividend Yield
★ 1.42%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 5.33
N/A
Revenue
★ $635,863,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.22
N/A
P/E Ratio
$20.52
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$97.27
$17.06
52 Week High
$148.00
$35.75

Technical Indicators

Market Signals
Indicator
LNN
SGP
Relative Strength Index (RSI) 43.77 77.19
Support Level $104.33 $24.85
Resistance Level $116.75 N/A
Average True Range (ATR) 3.66 2.05
MACD 0.27 0.67
Stochastic Oscillator 38.75 98.00

Price Performance

Historical Comparison
LNN
SGP

About LNN Lindsay Corporation

Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: